OMNi-BiOTiC
Commercial- Indications
- Gut health, Immune support
Company intelligence / Profile preview
Institut AllergoSan has over three decades of experience in developing evidence-based probiotics and natural supplements. Its flagship brand OMNi-BiOTiC® has become one of the top global probiotic brands—ranked #3 worldwide as of recent years—and its products are available in over forty countries. The company collaborates with international researchers to develop multi-strain probiotics for specific medical indications such as antibiotic-associated diarrhea, metabolic syndrome/type II diabetes risk factors, stress-induced gut dysfunctions, and more. Clinical results have been published in peer-reviewed journals supporting efficacy for several indications.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institut AllergoSan.